Abstract
We have previously shown that loss of heterozygosity (LOH) on human chromosome (hchr) 7 at q31.1 is common in a variety of tumors of epithelial origin. Frequent LOH of a specific chromosomal marker is indicative of a closely linked tumor suppressor gene (TSG). However, recent reports have also indicated that such a high frequency of LOH could be due to the presence in this region of the second most common aphidicolin-inducible fragile site in the human genome (Fra7G). To address this controversy, we introduced single copies of hchr7 or hchr12 into a highly aggressive human prostate carcinoma cell line (PC3) by microcell-mediated transfer. The tumorigenicity of six clones of PC3/hchr7 hybrids and three clones of PCRhchr12 hybrids, obtained in four separate fusion experiments, were studied in BALB/c nude mice. All but one of the PC3/hchr7 hybrids increased tumor latency by at least twofold, whereas none of the PC3/hchr12 hybrids delayed tumor onset. No differences in the in vitro growth rate were observed among any of the cell lines assayed (parental and hybrids) suggesting that the observed tumor suppression was due to factors other than cell cycle regulation. Deletion mapping of the PC3/hchr7 tumors obtained after reversion to the malignant phenotype revealed a common region of loss centred around 7q31.1, supporting the TSG hypothesis. The smallest commonly deleted region was ∼1.5 Mb in size and flanked by the markers D7S486 and D7S655.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- LOH:
-
loss of heterozygosity
- TSG:
-
tumor suppressor gene
- hchr:
-
human chromosome
References
Achille A, Biasi MO, Zamboni G, Bogina G, Magalini AR, Pederzoli P, Perucho M and Scarpa A . 1996 Cancer Res 56: 3808–3813
Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R and Lidereau R . 1992 Lancet 339: 139–143
Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI and Stanbridge EJ . 1998 Proc Natl Acad Sci USA 95: 3042–3047
Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S and Jenkins RB . 1996 Cancer Res 56: 4475–4482
Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC and Isaacs WB . 1995 Cancer Res 55: 4813–4817
Gupta PK, Sahota A, Boyadjiev SA, Bye S, Shao C, O'Neill JP, Hunter TC, Albertini RJ, Stambrook PJ and Tischfield JA . 1997 Cancer Res 57: 1188–1193
Huang H, Qian C, Jenkins RB and Smith DI . 1998b Genes Chromo Cancer 21: 152–159
Huang H, Qian J, Proffit J, Wilber K, Jenkins R and Smith DI . 1998a Oncogene 16: 2311–2319
Huebner K, Hadaczek P, Siprashvili Z, Druck T and Croce CM . 1997 Biochim Biophys Acta 1332: M65–M70
Kaighn ME, Lechner JF, Narayan KS and Jones LW . 1978 Natl Cancer Inst Monogr 49: 17–21
Koike M, Takeuchi S, Yokota J, Park S, Hatta Y, Miller CW, Tsuruoka N and Koeffler HP . 1997 Genes Chromo Cancer 19: 1–5
Kuniyasu H, Yasui W, Yokozaki H, Akagi M, Akama Y, Kitahara K, Fujii K and Tahara E . 1996 Int J Cancer 59: 597–600
Matsuda T, Sasaki M, Kato H, Yamada H, Cohen M, Barrett JC, Oshimura M and Wake N . 1997 Oncogene 15: 2773–2781
Neuman WL, Rubin CM, Rios RB, Larson RA, LeBeau MM, Rowley JD, Vardiman JW, Schwartz JL and Farber RA . 1992 Blood 79: 1501–1510
Nishizuka S, Tamura G, Terashima M and Satodate R . 1997 Br J Cancer 76: 1567–1571
Oakahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN and Jenkins RB . 1995 Cancer Res 55: 4114–4119
Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M and Oishi M . 1993 Mol Cell Biol 13: 6036–6043
Sanchez Y, Lovell M, Marin MC, Wong PE, Wolf-Ledbetter ME, McDonnell TJ and Killary AM . 1996 Proc Natl Acad Sci USA 93: 2551–2556
Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J and Smith DI . 1997 Oncogene 15: 2727–2733
Szeles A, Yang Y, Sandlund AM, Kholodnyuk I, Kiss H, Kost-Alimova M, Zabarovsky ER, Stanbridge E, Klein G and Imreh S . 1997 Genes Chromo Cancer 20: 329–336
Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G and Lathrop MA . 1992 Nature 359: 794–801
Zar JH . 1996 Biostatistical Analysis Chapter 16 Prentice-Hall Upper Saddle River, NJ, USA pp162–184
Zenklusen JC and Conti CJ . 1996 Mol Carcinog 15: 167–175
Zenklusen JC, Bieche I, Lidereau R and Conti CJ . 1994a Proc Natl Acad Sci USA 91: 12155–12158
Zenklusen JC, Oshimura M, Barrett JC and Conti CJ . 1994c Oncogene 9: 2817–2825
Zenklusen JC, Thompson JC, Klein-Szanto AJ and Conti CJ . 1995b Cancer Res 55: 1347–1350
Zenklusen JC, Thompson JC, Troncoso P, Kagan J and Conti CJ . 1994b Cancer Res 54: 6370–6373
Zenklusen JC, Weintraub LA and Green ED . 1999 Neoplasia 1: 16–22
Zenklusen JC, Weitzel JN, Ball HG and Conti CJ . 1995a Oncogene 11: 359–363
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zenklusen, J., Hodges, L., LaCava, M. et al. Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site. Oncogene 19, 1729–1733 (2000). https://doi.org/10.1038/sj.onc.1203488
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203488
Keywords
This article is cited by
-
ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix
Oncogene (2006)
-
Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas
British Journal of Cancer (2004)
-
Telomerase activity in human leukemic cells with or without monosomy 7 or 7q-
BMC Medical Genetics (2002)
-
Prostate Cancer Aggressiveness Locus on Chromosome 7832-q33 Identified by Linkage and Allelic Imbalance Studies
Neoplasia (2002)
-
Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers
Oncogene (2002)